Increased risk of depression in patients with Parkinson disease: A nationwide cohort study

American Journal of Geriatric Psychiatry

Volumn 23, Issue 9, 2015, Pages 934-940

  Hsu, Yi Ting ^a,b   Liao, Chien Chang ^a,c,d,e   Chang, Shih Ni ^a   Yang, Yu Wan ^a,b   Tsai, Chon Haw ^a,b   Chen, Ta Liang ^c,d,e   Sung, Fung Chang ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cohort study; Depression; Parkinson disease

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCOME; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSTEOPOROSIS; PARKINSON DISEASE; RENAL REPLACEMENT THERAPY; SOCIAL STATUS; TAIWAN; URBANIZATION; AGE; COMORBIDITY; COMPLICATION; INCIDENCE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 84942792126     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2014.10.011     Document Type: Article

References (33)

1. Reijnders JS, Ehrt U, Weber WE, et al: A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23:183-189
2. Cummings JL: Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149:443-454
3. Findley L, Aujla M, Bain PG, et al: Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003; 18:1139-1145
4. Barone P, Antonini A, Colosimo C, et al: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649
5. Marder K, Tang MX, Cote L, et al: The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995; 52:695-701
6. Nilsson FM, Kessing LV, Bolwig TG: Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001; 104:380-386
7. Schuurman AG, van den Akker M, Ensinck KT, et al: Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 2002; 58:1501-1504
8. Leentjens AF, Van den Akker M, Metsemakers JF, et al: Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003; 18:414-418
9. Aarsland D, Bronnick K, Alves G, et al: The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930
10. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, et al: Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008; 23:1889-1896
11. Becker C, Brobert GP, Johansson S, et al: Risk of incident depression in patients with Parkinson disease in the UK. Eur J Neurol 2011; 18:448-453
12. Cheng TM: Taiwan's new national health insurance program: genesis and experience so far. Health Aff 2003; 22:61-76
13. Liao CC, Shen WW, Chang CC, et al: Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg 2013; 257:433-438
14. Liao CC, Chiu WT, Yeh CC, et al: Risk and outcomes for traumatic brain injury in patients with mental disorders. J Neurol Neurosurg Psychiatry 2012; 83:1186-1192
15. Cheng CL, Kao YH, Lin SJ, et al: Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20:236-242
16. Mackenbach JP, Stirbu I, Roskam AJ, et al: Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008; 358:2468-2481
17. Fein O: The influence of social class on health status: American and British research on health inequalities. J Gen Intern Med 1995; 10:577-586
18. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, et al: Metabolic syndrome predisposes to depressive symptoms: a populationbased 7-year follow-up study. J Clin Psychiatry 2008; 69:178-182
19. Skilton MR, Moulin P, Terra JL, et al: Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007; 62:1251-1257
20. Hu G, Antikainen R, Jousilahti P, et al: Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70:1972-1979
21. Simon KC, Chen H, Schwarzschild M, et al: Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007; 69:1688-1695
22. Tandberg E, Larsen JP, Aarsland D, et al: The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996; 53:175-179
23. Schrag A, Jahanshahi M, Quinn NP: What contributes to depression in Parkinson's disease? Psychol Med 2001; 31:65-73
24. Boorsma M, Joling K, Dussel M, et al: The incidence of depression and its risk factors in Dutch nursing homes and residential care homes. Am J Geriatr Psychiatry 2012; 20: 932-942
25. Aarsland D, Påhlhagen S, Ballard CG, et al: Depression in Parkinson disease: epidemiology, mechanisms and management. Nat Rev Neurol 2011; 8:35-47
26. McDonald WM, Richard IH, DeLong MR: Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003; 54:363-375
27. Richard IH, Frank S, McDermott MP, et al: The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations. Cogn Behav Neurol 2004; 17:201-207
28. Mayeux R: The "serotonin hypothesis" for depression in Parkinson's disease. Adv Neurol 1990; 53:163-166
29. Fibiger HC: The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Can J Neurol Sci 1984; 11: 105-107
30. Frisina PG, Haroutunian V, Libow LS: The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat Disord 2009; 15:144-148
31. Remy P, Doder M, Lees A, et al: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128:1314-1322
32. Willis GL: Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 2008; 19:245-316
33. Rod NH, Bordelon Y, Thompson A, et al: Major life events and development of major depression in Parkinson's disease patients. Eur J Neurol 2013; 20:663-670